CDH1 and gastric cancer: CDH1 alterations are believed to be 20% of epigenetic nature and 10% of structural nature, and gastric cancer (GC) patients with CDH1 structural alterations displayed a significantly more dismal prognosis than patients with tumors lacking CDH1 alterations or harboring epigenetic CDH1 aberrations [19].